Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y. Nuki
Letter: CYP2C19 Polymorphisms and Exacerbation of Rabeprazole's Effects on Celecoxib-Induced Small Bowel Injury-Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
The Influence of CYP2C19 Polymorphisms on Exacerbating Effect of Rabeprazole in Celecoxib-Induced Small Bowel Injury
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Letter: CYP2C19 Polymorphisms and Exacerbation of Rabeprazole's Effects on Celecoxib-Induced Small Bowel Injury
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Hydration and Contrast-Induced Kidney Injury – Authors' Reply
The Lancet
Medicine
Letter: Phenotype and Natural History of Elderly Onset Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Causes of Fatigue in Inflammatory Bowel Disease Remain Uncertain - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Screening for Adrenal Suppression in Paediatric Inflammatory Bowel Disease - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Infliximab Therapy for Patients With Inflammatory Bowel Disease - Some Unanswered Questions. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
